Diabetes - Perspectives in Drug Therapy

Every 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its g...

Full description

Bibliographic Details
Other Authors: Schwanstecher, Mathias (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 2011, 2011
Edition:1st ed. 2011
Series:Handbook of Experimental Pharmacology
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 01722nmm a2200349 u 4500
001 EB000385771
003 EBX01000000000000000238823
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9783642172144 
100 1 |a Schwanstecher, Mathias  |e [editor] 
245 0 0 |a Diabetes - Perspectives in Drug Therapy  |h Elektronische Ressource  |c edited by Mathias Schwanstecher 
250 |a 1st ed. 2011 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 2011, 2011 
300 |a XIII, 408 p. 69 illus  |b online resource 
653 |a Molecular Medicine 
653 |a Molecular biology 
653 |a Cell biology 
653 |a Human Physiology 
653 |a Internal medicine 
653 |a Human physiology 
653 |a Internal Medicine 
653 |a Pharmacology 
653 |a Cell Biology 
653 |a Pharmacology/Toxicology 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Handbook of Experimental Pharmacology 
856 4 0 |u https://doi.org/10.1007/978-3-642-17214-4?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 615 
520 |a Every 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its ghastly toll. The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field